GlassScriptPhysician profile
Monty C Morales
NPI 1043298656
$39,331.73
in general payments reported to CMS, 2019-2025
43 companies · $1,621 in 2025
The $1,621 reported for 2025 was more than what 80% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,402 · 2020: $6,955 · 2021: $7,918 · 2022: $4,297 · 2023: $7,184 · 2024: $1,954 · 2025: $1,621.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,060 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,200 · Consulting Fee: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,059.61 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,200.00 |
| Consulting Fee | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $11,277.14 | 2021-2025 | Venaseal, Closurefast, Micra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $8,960.16 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $3,024.67 | 2019-2025 | Watchman Flx, Watchman Access System, Varithena Administration Pack |
| Abbott Laboratories | $2,964.86 | 2019-2025 | Perclose Prostyle, Esprit, Assurity |
| Medtronic Vascular, INC. | $2,425.34 | 2019-2020 | |
| Abiomed | $1,266.99 | 2019-2024 | Impella |
| Acutus Medical, INC. | $1,109.82 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $1,050.74 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $797.63 | 2019-2025 | |
| Kestra Medical Technology Services, INC. | $703.91 | 2022-2025 | Assure Wcd |
| Provisio Medical, INC. | $500.00 | 2023 | |
| Philips North America LLC | $487.79 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $461.25 | 2019-2025 | Jardiance |
| Pfizer INC. | $426.77 | 2021-2025 | |
| Biotronik INC. | $412.90 | 2019 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $400.79 | 2020-2025 | Repatha, Repatha |
| Terumo Medical Corporation | $304.59 | 2021-2024 | Metacross Otw, Glidesheath Slender, Glidewire |
| Zoll Respicardia, INC. | $265.12 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $241.67 | 2019-2025 | Camzyos, Eliquis |
| Tactile Systems Technology INC | $239.68 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $210.60 | 2022 | |
| Recor Medical INC | $178.02 | 2024-2025 | Paradise Renal Denervation System, Paradise Ultrasound Renal Denervation System |
| Kowa Pharmaceuticals America, INC. | $165.10 | 2019-2020 | |
| Esperion Therapeutics, INC. | $158.99 | 2021-2024 | Nexletol |
| Cvrx, INC. | $149.21 | 2024-2025 | Barostim Neo System |
| Covidien LP | $133.09 | 2019 | |
| Impulse Dynamics (USA) INC. | $126.53 | 2021-2023 | Optimizer |
| Merck Sharp & Dohme LLC | $122.17 | 2022-2025 | Verquvo |
| Ekos Corporation | $97.18 | 2019 | |
| Amarin Pharma, INC. | $89.14 | 2020-2022 | |
| Novo Nordisk INC | $81.73 | 2021-2025 | Ozempic, Wegovy |
| Chiesi USA, INC. | $78.91 | 2019-2023 | Kengreal, Cleviprex |
| Edwards Lifesciences Corporation | $61.76 | 2025 | Pascal |
| Sanofi-Aventis U.S. LLC | $57.93 | 2021-2022 | |
| Inari Medical, INC. | $45.74 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Scpharmaceuticals INC. | $44.99 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $42.50 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $41.37 | 2019 | |
| Endologix LLC | $37.00 | 2024 | Afx2 Bifurcated Endograft System |
| Shockwave Medical, INC | $30.27 | 2021 | |
| Alnylam Pharmaceuticals INC. | $28.98 | 2025 | Amvuttra |
| Saranas, INC. | $15.77 | 2022 | |
| Allergan, INC. | $12.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monty Morales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.